Evaluating Communication in Cancer Clinics with TrialTalk™
This study is looking at how well patients and their healthcare team communicate in cancer clinics. It's testing a communication tool called TrialTalk™ to see if it can make these conversations better. TrialTalk™ aims to help make your treatment options clear and involve you more in discussions. You might be able to join if you are an adult (18 or older) with a cancer diagnosis, identify as Black, African American, or non-Hispanic White, and could be eligible for another cancer clinical trial. The study will measure if TrialTalk™ helps providers communicate better and if the tool is used consistently over time. We also want to see if the quality of communication improves. The study is currently recruiting about 30 participants.
- Study design
- This is an interventional study, meaning participants will receive an intervention (TrialTalk™). It plans to enroll 30 participants.
- What's involved
- You will complete questionnaires before and after your standard clinic visits.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will track the sustainability of the TrialTalk™ tool for up to 1 year, and changes in communication quality for up to 2 hours.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluating the Communication Between Patients and Providers in Cancer Clinics
At a glance
Conditions
Where it's being run
3 sites across 3 statesStudy leadership
- Monica Patel, MD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Fidelity - ProvidersMonthly for 6 months
Fidelity to the tool by providers is measured by a 9 item qualitative questionnaire, asking how many times and how providers used TrialTalk™ when talking with their patients.
- Sustainability of TrialTalk™ communication tool1 year
Providers will answer a 3 item questionnaire regarding their use of TrialTalk™. Items are scored on a 5 point Likert scale, where 1 = not at all and 5 = very much. Higher scores indicate better sustainability of the tool.
- Change in quality of communicationUp to 2 hours
Patient participants will rate the quality of communication they receive from their provider. They will answer a 13 item questionnaire with a 6-point Likert scale, where 0= not done and 5 = excellent. Scores range from 0-65, with higher scores indicating better communication.
- Change in trust of providerUp to 2 hours
Patient participants will rate how much they trust their provider using a 6 item questionnaire. Scores are on a 5-point Likert scale, where 1 = not at all and 5 = extremely. Scores range from 6-30, with higher scores indicating greater trust.
- Usefulness of toolUp to 2 hours
Patient participants will complete a 7 item questionnaire about the visual diagram created with their provider. It is scored on a 5-point Likert scale, where 1 = not at all and 5 = extremely. Scores range from 7-35, with higher scores indicating greater usefulness.
- Understanding of treatment optionsUp to 2 hours
Patient participants will answer 9 yes or no questions regarding how well they understood the options presented to them during the visit.